287 related articles for article (PubMed ID: 32279584)
21. Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome.
Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Zhou Z; Jia J; Wang Z; Zhou J; Norman GL; Wang X; Yang C; Shi H
Thromb Res; 2020 Jan; 185():142-149. PubMed ID: 31816554
[TBL] [Abstract][Full Text] [Related]
22. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
Kopytek M; Natorska J; Undas A
Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
[TBL] [Abstract][Full Text] [Related]
23. Beyond the classics: The emerging value of anti-phosphatidylserine/prothrombin antibodies in antiphospholipid syndrome.
Ding Z; Pan H; Yang Z; Yang C; Shi H
Clin Immunol; 2023 Nov; 256():109804. PubMed ID: 37838215
[TBL] [Abstract][Full Text] [Related]
24. GAPSS: the Global Anti-Phospholipid Syndrome Score.
Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
Rheumatology (Oxford); 2013 Aug; 52(8):1397-403. PubMed ID: 23315788
[TBL] [Abstract][Full Text] [Related]
25. The global anti-phospholipid syndrome score in primary APS.
Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
Rheumatology (Oxford); 2015 Jan; 54(1):134-8. PubMed ID: 25122726
[TBL] [Abstract][Full Text] [Related]
26. [Influencing factors of thrombosis besides antiphospholipid antibodies in patients with antiphospholipid syndrome].
Fan YY; Chen C; Liu HJ; Cai WX; Hou YK; Li C
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(43):3588-3593. PubMed ID: 34808753
[No Abstract] [Full Text] [Related]
27. Independent validation of the adjusted GAPSS: Role of thrombotic risk assessment in the real-life setting.
Fernandez Mosteirin N; Saez Comet L; Salvador Osuna C; Calvo Villas JM; Velilla Marco J
Lupus; 2017 Oct; 26(12):1328-1332. PubMed ID: 28387637
[TBL] [Abstract][Full Text] [Related]
28. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
Thromb Haemost; 2014 Feb; 111(2):354-64. PubMed ID: 24172938
[TBL] [Abstract][Full Text] [Related]
29. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
30. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
31. Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus.
Akhter E; Shums Z; Norman GL; Binder W; Fang H; Petri M
J Rheumatol; 2013 Mar; 40(3):282-6. PubMed ID: 23378459
[TBL] [Abstract][Full Text] [Related]
32. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
[TBL] [Abstract][Full Text] [Related]
33. Laboratory Evaluation of Antiphospholipid Syndrome.
Heikal N; Martins TB; White SK; Willis R; Ware Branch D; Schmidt RL; Tebo AE
Am J Clin Pathol; 2019 Oct; 152(5):638-646. PubMed ID: 31305881
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
[TBL] [Abstract][Full Text] [Related]
35. Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies.
Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S
Immunol Res; 2021 Aug; 69(4):372-377. PubMed ID: 34245429
[TBL] [Abstract][Full Text] [Related]
36. Double positivity of anti-β
Yun J; Gu J; Kim HK
J Thromb Thrombolysis; 2021 Nov; 52(4):1133-1136. PubMed ID: 33914240
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
38. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
[TBL] [Abstract][Full Text] [Related]
39. Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome.
Bradáčová P; Slavík L; Skoumalová A; Úlehlová J; Kriegová E; Manukyan G; Friedecký D; Piskláková B; Ullrychová J; Procházková J; Hluší A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012233
[TBL] [Abstract][Full Text] [Related]
40. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study.
Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N
Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
